Printer Friendly

IMMUCOR SEES FLAT EARNINGS FOR FISCAL YEAR

 IMMUCOR SEES FLAT EARNINGS FOR FISCAL YEAR
 NORCROSS, Ga., July 2 /PRNewswire/ -- Immucor, Inc.


(NASDAQ-NMS: BLUD), maker of blood bank reagent systems and related products, announced today the company expects to report a decline in fourth quarter earnings, and flat year-end earnings, as compared to the same periods last year.
 "Our year-end audit is in process, and final results will not be available for several weeks. However, based upon preliminary information, we see a decline in fourth quarter net income of approximately 20-25 percent as compared to a year ago," said Edward L. Gallup, president of Immucor. "As a result, year-end net income is expected to be approximately equal to last year's $3.1 million, with earnings per share around 10 percent less than last year's $.38, due to an increase in the weighted average number of common shares and common share equivalents."
 Founded in 1982, Immucor manufactures and sells a complete line of reagents and systems used primarily by hospitals and blood banks in a number of tests performed to detect and identify certain properties of the cell and serum components of human blood prior to blood transfusion. Through its German and Italian subsidiaries, the company also sells blood bags for the collection, storage and administration of human blood, HLA products used primarily in human organ transplantation, DNA probes used in paternity testing and forensic medicine, and tests for certain infectious diseases.
 -0- 7/2/92
 /CONTACT: Richard J. Still, senior vice president - Finance of Immucor, 404-441-2051/
 (BLUD) CO: Immucor, Inc. ST: Georgia IN: MTC SU: ERP


BN-CF -- AT002 -- 6005 07/02/92 07:59 EDT
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Jul 2, 1992
Words:267
Previous Article:LEAR SEATS IN 1 MILLIONTH CORVETTE
Next Article:NEW JERSEY'S HEALTH CARE CRISIS FOCUS FOR CABLE SPECIAL
Topics:


Related Articles
IMMUCOR REPORTS THIRD QUARTER RESULTS
IMMUCOR REPORTS YEAR-END AND FOURTH QUARTER RESULTS
IMMUCOR REPORTS FIRST QUARTER RESULTS
IMMUCOR REPORTS THIRD QUARTER RESULTS
IMMUCOR REPORTS YEAR-END AND FOURTH QUARTER RESULTS
IMMUCOR REPORTS SECOND QUARTER RESULTS
IMMUCOR REPORTS THIRD QUARTER RESULTS
IMMUCOR REPORTS SECOND QUARTER RESULTS
IMMUCOR REPORTS THIRD QUARTER RESULTS
IMMUCOR REPORTS YEAR END RESULTS

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters